Effect of angiotensin-converting enzyme inhibitors on hematological parameters and recombinant human erythropoietin doses in peritoneal dialysis patients.
Navarro
J F
JF
Department of Nephrology, Hospital Ntra. Sra. De Candelaria, Santa Cruz de Tenerife, Spain. jgarcia@esintet.es
Mora
C
C
Rivero
A
A
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000627:therapeutic use*; D006403:Hematologic Tests; D006801:Humans; D010530:Peritoneal Dialysis; D011994:Recombinant Proteins
D000806:Angiotensin-Converting Enzyme Inhibitors; D011994:Recombinant Proteins; D004921:Erythropoietin